Dovobet® (Calcipotriol and Betamethasone Dipropionate) - A - Detailing from Skin Therapy Letter

 

Dovobet® (Calcipotriol and Betamethasone Dipropionate)

 

 

  Content:

CLINICAL EXPERIENCE

 

 


  • More than six international studies involving over 6,000 patients have shown reductions in the PASI (Psoriasis Area and Severity Index) of approximately 40% after one week of treatment and 70% after four weeks.
  • Dovonex (50 micrograms/gram calcipotriol) is often prescribed after four weeks of Dovobet therapy for ongoing maintenance. In practice ongoing use of Dovobet such as on weekends only is common.
  • Dovobet is well tolerated. Side effects are minimal: some 5% to 10% of patients report itching or other lesional or perilesional adverse reactions.

Next:   Indications

 

 

    More Presentations: